Comparative Evaluation of Pioglitazone versus Voglibose on Lipid Profile in Patients with Type 2 Diabetes Mellitus Add On Metformin

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2018, Vol 6, Issue 9

Abstract

Type 2 Diabetes mellitus (Type 2 DM) is a heterogeneous group of disorders associated with both macrovascular and microvascular complications. Due to progressive nature of type 2 DM, dual drug therapy produces additive effects, allows the use of submaximal doses, and less side effects of individual agents. Therefore, the present study was designed to study the effect of pioglitazone in comparison to voglibose on Lipid profile control as an add-on drug in patients with Type 2 DM whose glycemic status was uncontrolled with metformin alone. The present study was open, randomized parallel group comparison of two active treatment groups over a period of six months. Sixty-seven patients of either sex in the age group of 30-60 years, suffering from type 2 DM, with FBG ≥ 126 mg/dl and PPBG ≥ 200 mg/dl as per ADA were selected at randomly. The effect of pioglitazone and voglibose were observed on various parameters of Lipid Profile (Total cholesterol, TG, HDL, LDL, VLDL). At the end of 6 months it was observed that though both pioglitazone and voglibose reduced Lipid levels significantly but pioglitazone caused a significantly greater percentage change in Lipid levels as compared with voglibose. Few side effects were observed with voglibose and not with pioglitazone. Though pioglitazone and voglibose were equally effective in lowering Lipid levels yet pioglitazone showed better results in improving dyslipidemia, as compared to voglibose. Pioglitazone had minimal side effects as compared to voglibose.

Authors and Affiliations

MD Faheem Mubeen, Dr. Deepak Bhosle

Keywords

Related Articles

Factors that Motivate and Hinder Blood Donation among First Time Blood Donors

The increased demand of blood and its components makes it important for us to spread awareness of blood donation. We need to know the factors that may prompt a donor to donate blood or hinder him from doing so. 100 first...

A Study of Clinical Profile of Benign Breast Diseases Presenting at a Tertiary Care Centre in Central India

The objective of the work was to study the clinical profile of Benign Breast Diseases (BBD) and their correlation with ultrasonographic and histopathological findings at a tertiary care centre in Central India. The prese...

Systemic Inflammation and Nitric Oxide Levels in the Patients with Type 2 Diabetes Mellitus

Abstract: Presence of systemic inflammation is a hallmark of variety of pathophysiological such as hypertension, atherosclerosis, myocardial infarction and inflammatory joint diseases. Although previous evidences provide...

Plasma Total Antioxidant Activity and Its Relation with Serum Uric Acid in Type 2 Diabetes and Non Diabetes: A Comparative Study

Oxidative stress has been found to be associated with variety of diseases including diabetes. It is conceivable that alteration in plasma antioxidant reserve along with serum uric acid levels may have a crucial role in d...

A Systematic Review of Apoptosis

Apoptosis is a programmed cellular death involved in morphogenesis and homeostasis of organs and tissues. The survival of organisms depends on balance between cell proliferation and cell death. Apoptosis occurs in tissu...

Download PDF file
  • EP ID EP479697
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

MD Faheem Mubeen, Dr. Deepak Bhosle (2018). Comparative Evaluation of Pioglitazone versus Voglibose on Lipid Profile in Patients with Type 2 Diabetes Mellitus Add On Metformin. Scholars Journal of Applied Medical Sciences, 6(9), 3461-3471. https://europub.co.uk/articles/-A-479697